Os Therapies Inc (OSTX) SEC Filings — 2025

Filings

• OSTX Net Loss Soars 159% Amid R&D Surge, Cash Dwindles — 10-Q · Nov 14, 2025
• OS Therapies Inc. Files 8-K on Officer Changes and Shareholder Votes — 8-K · Oct 21, 2025
• OS Therapies Inc. Files DEFA14A for Annual Meeting — DEFA14A · Oct 17, 2025
• OS Therapies Inc. Files 8-K — 8-K · Sep 30, 2025
• OS Therapies Inc. Files 8-K with Material Agreements — 8-K · Sep 2, 2025
• OS Therapies Terminates Material Agreement — 8-K · Aug 26, 2025
• OS Therapies Files Definitive Additional Materials — DEFA14A · Aug 25, 2025
• OSTX Seeks Shareholder Nod for Major Equity Issuance, Tripling Authorized Shares — DEF 14A · Aug 25, 2025
• OS Therapies Inc. Files 8-K on Financials — 8-K · Aug 19, 2025
• OS Therapies Inc. Files Q2 2025 10-Q Report — 10-Q · Aug 18, 2025
• OS Therapies Inc. Files 8-K with Corporate Updates — 8-K · Aug 15, 2025
• OS Therapies Files S-1 for Public Offering, Signals Growth Ambition — S-1 · Aug 4, 2025
• OS Therapies Inc. Files 8-K: Material Agreement, Equity Sales — 8-K · Jul 14, 2025
• OS Therapies Inc. Files 8-K: Material Agreement & Equity Sales — 8-K · Jun 27, 2025
• OS Therapies Inc. Files 8-K for Material Agreement & Equity Sales — 8-K · Jun 24, 2025
• OS Therapies Files S-1 for Public Offering, Eyes Capital Infusion — S-1 · May 23, 2025
• OS Therapies Inc. Files 8-K on Financials — 8-K · May 16, 2025
• OS Therapies Inc. Files Q1 2025 10-Q Report — 10-Q · May 15, 2025
• OS Therapies Inc. Completes Acquisition, Reports Equity Sales — 8-K · Apr 15, 2025
• OS Therapies Files 8-K on Shareholder Votes & Financials — 8-K · Apr 9, 2025
• OS Therapies Files 8-K for March 31, 2025 — 8-K · Apr 2, 2025
• OS Therapies Inc. Files 2024 Annual Report — 10-K · Mar 31, 2025
• OS Therapies Inc. Files Definitive Proxy Statement — DEF 14A · Feb 28, 2025
• OS Therapies Inc. Files S-1 for Public Offering — S-1 · Jan 31, 2025
• OS Therapies Files 8-K: Agreements, Equity Sales, Officer Changes — 8-K · Jan 29, 2025
• OS Therapies to Acquire Ocuphire Pharma for $0.70/Share — 8-K · Jan 15, 2025
• OS Therapies Inc. Files 8-K: Material Agreement & Equity Sales — 8-K · Jan 14, 2025
• OS Therapies Inc. Files 8-K for Material Agreement — 8-K · Jan 3, 2025